And some useful links on this topic on Russian:
1.Kazak National Center of Expertize of Medicines and Medical Devices
2.Kazak national database of registered medicines and medical devices
And some useful links on this topic on Russian:
1.Kazak National Center of Expertize of Medicines and Medical Devices
2.Kazak national database of registered medicines and medical devices
October 2014 was remarkable with a series of “big events” on the Russian regulatory landscape which opened up possibilities to get first-hand information from Russian regulatory bodies: a public seminar by Roszdravnadzor on clinical trials, a big conference “Farmmedobrashenie” and a public discussion on “Federal Act on Medical Devices”.
The first interesting statistics on registration of medical devices for this year appeared: the Head of Medical Device registration department announced that there were 1176 positive and 428 negative expertises for registration of medical devices in 2014. It was also stated that after new amendments to registration rules came into force in July, the number of positive outcomes has been rising rapidly, more than tripling, and the quantity of negative outcomes for last two months consisted of 7%.
But…here are the three most important news items I would like to highlight:
As you know, medical devices that use high frequency signals could be subject of special regulations in addition to state registration. Let`s have a closer look on this topic for Russia.
On the 2nd of October 2014 Russian medical device regulator Roszdravnadzor organised a one-day seminar fully devoted to different aspects of clinical trials for registration of medical and in-vitro devices. More than 100 questions on this topic were put to officials by representatives of international medical device manufacturers and local clinics. Below I would like to post ten the most interesting of them answered:
1. Regulations permit two forms of clinical trials: evaluation of clinical data without patient involvement and full-scale clinical trials with patients. Who decides the form in which clinical trials will be required for registration in my particular case? According to regulations, full-scale clinical trials with involvement of patients are required for registration of new types of devices and new treatments or diagnostic methods as well as in cases when safety of medical devices has not been proved with evaluation of clinical data. In the near future Roszdravnadzor expects that all implantable 2b and 3 class medical devices will pass through full-scale clinical trials with patients. Currently, a clinic or trial centre decides if full-scale or reduced trials are required for every particular case.
2. Are clinical trials programmes (plans) and clinical data mandatory in the registration dossier? Yes. Roszdravnadzor confirmed that clinical trials plans and clinical data must be submitted in the first step of the registration (before expertise).
3. Who draws up the plan/programme of clinical trials? Local clinics or trial centres are responsible for composing the plan of the trials together with applicant for registration of the medical device in question. The clinic should be accredited by Roszdravnadzor. ISO 14155 is recommended for trial plans.
4. At what point are clinical trials officially started? Current regulations do not clarify this. The start of clinical trials could be considered as the point of signature of a contract with a clinic or an initial clinical visit or signature of informed consent from the first patient. Applicants must inform Roszdravnadzor about the start of clinical trials for their device within five business days.
5. Is an ethical committee mandatory for clinical trials? Roszdravnadzor confirmed that an ethical committee has worked within the Ministry of Health since July 2014. All clinical trials on patients must be approved by the ethical committee. The procedure of assessment of clinical data should be agreed by the ethical committee only if this data contains personal information of patients.
6. Is the ISO 14155 standard mandatory for clinical trials? National standards are not mandatory in Russia. Meanwhile it should be noted that this standard is considered a minimal requirement. In cases when companies or clinics do not have their own standards or procedures, ISO 14155 is highly recommended
7. What documents are needed to start full-scale clinical trials? Two documents are mandatory for any clinical trial on patients: authorisation from Roszdravnadzor and approval from the ethical committee.
8. Can clinical trials for registration in Russia be performed abroad? Yes. Clinical trials can be performed out of Russia if samples of the device cannot be shipped in the country because of technical reasons (e.g. equipment requires complex installation). In such cases trials must be performed by Russian experts from clinics accredited by Roszdravnadzor during inspection visits. Places where trials have been performed should be noted in the clinical report.
9. How many samples do we need for trials? Samples of medical devices must be provided to the clinic in cases of full-scale clinical trials and clinical data assessment. The quantity of samples required is defined by clinics for every particular case. Samples must be imported according to special procedures with permission issued by regulator.
10. Is it allowed by law to pay patients for participation in clinical trials? Yes, but any payment to a patient must be agreed by the ethical committee of the Ministry of Health.
September saw the introduction of regulatory initiatives which sometimes provoked new questions. Two main aspects of the development of medical device regulations include work on Eurasian medical device guidelines (for which there was no noticeable progress last month) and new legal acts for Russia:
Published Order #698, which defines the rules for grouping implantable medical devices in official lists subject to state reimbursement programmes, was the subject of much debate within the Russian medical device industry in September. For future state reimbursement programmes of gratuitous medical treatment system a medical device must be included in this list by a special MoH commission which follows a thirty day procedure. The list should be in line with medical device classification and consist of medical devices registered in Russia based on clinical safety data/justification additionally requested by the commission. The order imposed very strict deadlines for application for inclusion on the current list (as of the 6th of October 2014), but there is not yet a clear list of documents required for submission, the MoH commission still doesn’t exist and the new medical device classifications described in the procedure is far from clear.
From the beginning of 2013, new Russian medical device regulations caused confusion over the applicability of VAT for medical device importation. This was largely due to differences in terminology between these guidelines and the Russian tax code. Changes in the Russian tax code in November 2013 made the situation clearer, but the positions of different Russian localities on providing preferential VAT rates for importation remained ambiguous. Government Resolution #870 came into force on the 9th of September 2014, thereby clarifying terminology and confirming the list of medical devices subject to 10% VAT during importation in Russia. Hopefully this will put an end to the lack of clarity for this group of medical products. A government order with a similar list of medical devices subject to 0% VAT is expected within the next few months.
The Russian Ministry of Health published a notice about the development of a federal law on circulation of medical devices. The draft of the law is intended to ensure quality, safety and efficacy at every stage of the medical device lifecycle. It is commonly known that this type of unified legal framework is currently missing in Russia, resulting in a number of contradictions between the various regulatory acts in the medical device domain. The MoH announced the target date for this law as January 2016. The text of the current version of the document is currently officially unavailable, and as such it is still unclear how this law will accord with further medical device regulation of Eurasian customs union.
Full text of regulations on medical device labeling requirements in Kazakhstan (Order 1692 dated 30/12/2011) is available in Russian
Ukrainian Government published 12 September 2014 new decree #410 defining the list of medical devices – subjects to 7% VAT for importation in the country. The list will replace old one, published in July 2014, which was significantly wider.
Full list is available in Ukrainian language on: http://zakon2.rada.gov.ua/laws/show/410-2014-%D0%BF